People Briefs: Calhoun Vision, Benvenue Medical, Urologix, Pentax
This article was originally published in The Gray Sheet
Executive Summary
Calhoun Vision appoints CEO. Urologix, Benvenue Medical hire CFOs. Pentax Medical promotion.
You may also be interested in...
FDA Lays Down Strict Disinfection Guidance In Wake Of Scope Incidents
The agency sped up release of a final guidance on reprocessing reusable devices, including a strict set of protocols for endoscope cleaning, disinfection data, and design guidelines, following reports of serious bacterial infections linked to duodenoscopes.
Benvenue Launches Kiva Armed With Favorable Study Results
Benvenue Medical Inc. announced the launch of its Kiva VCF Treatment System for vertebral compression fractures in the spine March 24, along with favorable data announced at a meeting of the Society of Interventional Radiology.
Bausch & Lomb Sold To Valeant Pharmaceuticals For $8.7 Billion
In the latest of more than a dozen acquisitions Valeant has made since it was created by a merger with Biovail SA in 2011, Valeant’s purchase of Bausch & Lomb will increase its eye care portfolio substantially.